AFP and cholangiocarcinoma: However, the sensitivity of these biomarkers in the detection of early HCC or small lesions is limited, and AFP levels may also be elevated in other malignancies (such as cholangiocarcinoma or colon cancer), as well as during flare-ups of chronic viral hepatitis, also in the absence of HCC [10].